Neuronetics Appoints Nir Naor as New CFO Amid SEC Scrutiny
Neuronetics (NASDAQ: STIM), a neurostimulation device maker, appointed Nir Naor as CFO on September 28, 2026. The move follows prior SEC inquiries into delayed filings and audit issues — indicating urgent need for strengthened financial oversight and SEC reporting rigor.
51CFO view：CFO appointment under SEC scrutiny demands immediate SOX 404 remediation, SEC comment letter resolution, and deep expertise in medtech revenue recognition (e.g., bundled lease-service models) and FDA-related R&D capitalization.
Neuronetics (NASDAQ: STIM), a neurostimulation device maker, appointed Nir Naor as CFO on September 28, 2026. The move follows prior SEC inquiries into delayed filings and audit issues — indicating urgent need for strengthened financial oversight and SEC reporting rigor.
Source：Google News · CFO 任命